ICLN vs XBI
iShares Global Clean Energy ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.39% for ICLN.
- • ICLN pays a higher dividend yield (0.90%).
Side-by-side metrics
| Metric | ICLN | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.39% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.90% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $2.91B | $10.73B |
YTD return | 16.26% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.43 | 1.10 |
P/E ratio | 21.00 | — |
Last price | $19.43 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
ICLN top holdings
| BE | Bloom Energy Corp Class A | 14.75% |
| FSLR | First Solar Inc | 8.41% |
| NXT | Nextpower Inc Class A | 7.32% |
| 600900.SS | China Yangtze Power Co Ltd Class A | 5.78% |
| ENPH | Enphase Energy Inc | 4.87% |
| VWS.CO | Vestas Wind Systems AS | 3.11% |
| PLUG | Plug Power Inc | 2.85% |
| SEDG | SolarEdge Technologies Inc | 2.65% |
| EQTL3.SA | Equatorial SA | 2.56% |
| SUZLON.BO | Suzlon Energy Ltd | 2.52% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About ICLN
ICLN (iShares Global Clean Energy ETF) is Global clean energy and renewable power companies. Managed by iShares, the fund carries $2.9B in assets under management, an expense ratio of 0.39%, a dividend yield of 0.90%. Its largest holding is Bloom Energy Corp Class A (BE), which represents 14.7% of the portfolio. Basic Materials is the fund's largest sector exposure at 1.5%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.